Plasmodium Resistance to Artemisinin Derivates due to Kelch-3 Gene Mutation

Authors

  • Reqgi First Trasi Universitas Sultan Ageng Tirtayasa, Kota Cilegon, Banten

DOI:

https://doi.org/10.32734/idjpcr.v4i2.6332

Keywords:

Antimalaria, resistance, artemisinin, plasmodium, mutation

Abstract

Artemisinin class of antimalarial drugs play an important role in controlling falciparum malaria after the emergence of resistance of Plasmodium falciparum to other antimalarial drugs such as chloroquine, sulfadoxine-pyrimethamine and mefloquine. Therefore, the presence of Plasmodium falciparum resistance to this class of drugs is threat to global efforts to eliminate this disease. Resistance of Plasmodium falciparum to artemisinin recently known to be associated with mutations in the propeller domain of the kelch-13 (K13) Plasmodium falciparum gene. The incidence of Plasmodium falciparum resistance due to mutations in the K13 gene, among others, can be found in Cambodia, Laos, Vietnam, China, Myanmar, Thailand and Africa. The presence of mutations in this gene will change the response of Plasmodium falciparum against oxidative stress induced by artemisinin by involving the proteasome-ubiquitin pathway. In addition, mutation K13 will also change the levels of PI3K and PI3P in the body of Plasmodium falciparum. PI3K and PI3P are lipids that essential for the development of Plasmodium falciparum from ring stage to schizont. Resistance to artemisinin will also provide phenotypic changes in the life cycle of Plasmodium falciparum in the form of elongation at the stage ring and transient shortening in trophozoite development. This resistance incident can be overcome, among others by prolonging the duration of treatment (from a 3-day regimen to a 4-day regimen) and combining artemisinin with proteasome inhibitors.

Downloads

Download data is not yet available.

References

Thu AM, Phyo AP, Landier J, Parker DM, Nosten FH. Combating multidrugresistant Plasmodium falciparum malaria. FEBS J. 2017;284(16):2569-78.

Hott A, Casandra D, Sparks KN, Morton LC, Castanares GG, Rutter A, dkk. Artemisinin-resistant Plasmodium falciparum parasites exhibit altered patterns of development in infected erythrocytes. Antimicrob Agents Chemother. 2015;59(6):3156-67.

Pandey N, Pandey-Rai S. Updates on artemisinin: an insight to mode of actions and strategies for enhanced global production. Protoplasma. 2016;253(1):15-30.

Dogovski C, Xie SC, Burgio G, Bridgford J, Mok S, McCaw JM, dkk. Targeting the Cell Stress Response of Plasmodium falciparum to Overcome Artemisinin Resistance. PLoS Biol. 2015;13(4):1-26.

Ho WE, Peh HY, Chan TK, Wong WSF. Artemisinins: Pharmacological actions beyond anti-malarial. Pharmacol Ther. 2014;142(1):126-39.

Zaw MT, Emran NA, Lin Z. Updates on k13 mutant alleles for artemisinin resistance in Plasmodium falciparum. J Microbiol Immunol Infect. 2017;51(2):159-16.

Straimer J, Gnädig NF, Stokes BH, Ehrenberger M, Crane A a, Fidock A. Plasmodium falciparum K13 Mutations Differentially Impact Ozonide Susceptibility and Parasite Fitness In Vitro. Am Soc Microbiol. 2017;8(2):1-12.

WHO. Status report on artemisinin and ACT resistance. Geneva: World Health Organization; 2016.

Miotto O, Amato R, Ashley EA, MacInnis B, Almagro-Garcia J, Amaratunga C, dkk. Genetic architecture of artemisininresistant Plasmodium falciparum. Nat Genet. 2015;47(3):226-34.

Fairhurst RM. Understanding artemisininresistant malaria: what a difference a year makes. Curr Opin Infect Dis. 2015;28(5):417-25.

Tilley L, Straimer J, Gnädig NF, Ralph SA, Fidock DA. Artemisinin Action and Resistance in Plasmodium falciparum. Trends Parasitol. 2016;32(9):682-96

Published

2021-12-30

How to Cite

Trasi, R. F. . (2021). Plasmodium Resistance to Artemisinin Derivates due to Kelch-3 Gene Mutation. Indonesian Journal of Pharmaceutical and Clinical Research, 4(2), 39-44. https://doi.org/10.32734/idjpcr.v4i2.6332